Wei Jiang - May 12, 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang
Stock symbol
STAA
Transactions as of
May 12, 2025
Transactions value $
$0
Form type
4
Date filed
5/13/2025, 06:02 PM
Previous filing
Apr 2, 2025
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jiang Wei Director 25510 COMMERCENTRE DRIVE, LAKE FOREST /s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang 2025-05-13 0001867980

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +62.9K $0.00 62.9K May 12, 2025 Common Stock 62.9K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 Award of RSUs granted to the Reporting Person on May 12, 2025. RSUs will vest as to 1/3 of the shares subject to the award on August 12, 2025, November 12, 2025, and January 12, 2026.

Remarks:

As disclosed in the Corporation's Current Report on Form 8-K filed on April 24, 2025, the Corporation entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy. This Form 4 reflects the RSUs granted to Mr. Jiang in connection with such service.